DEAE-Dextran Enhances the Lentiviral Transduction of Primary Human Mesenchymal Stromal Cells from All Major Tissue Sources Without Affecting Their Proliferation and Phenotype

Mol Biotechnol. 2023 Apr;65(4):544-555. doi: 10.1007/s12033-022-00549-2. Epub 2022 Aug 23.

Abstract

Genetic engineering of mesenchymal stromal cells (MSCs) is a tool widely used to explore MSC properties in vitro and in vivo. Lentiviral infection with the use of polycations as an adjuvant is a method that is commonly used to generate stably transduced cells. However, it is known that some polycations can negatively affect primary MSCs and to date, no study has explored the effect of different polycations on the transduction efficiency and properties of all main types of MSCs, namely those derived from umbilical cord, bone marrow and adipose tissue. Here we explore a range of polycations, using transduction protocols with and without spinoculation, to produce stably transduced MSCs from these three tissue sources. We identified that an overnight incubation with diethylaminoethyl-dextran (DEAE-Dextran) is the protocol associated with the best transduction efficiency without compromising the viability of the cells, and which worked consistently with lentiviral particles encoding for different transgenes. Transduced and sorted MSC populations revealed no significant changes in proliferation, morphology and expression of MSC markers compared to naïve MSCs. Following this study, we conclude that DEAE-Dextran is a polycation that can be successfully used to enhance the transduction of MSCs from all major tissue sources.

Keywords: Lentivirus; Mesenchymal stromal cells; Polycations; Reporter genes; Transduction.

MeSH terms

  • Cell Differentiation
  • Cell Proliferation
  • Cells, Cultured
  • DEAE-Dextran* / metabolism
  • Genetic Vectors / genetics
  • Humans
  • Lentivirus / genetics
  • Mesenchymal Stem Cells*
  • Phenotype
  • Transduction, Genetic

Substances

  • polycations
  • DEAE-Dextran